Skip to content
Brief

Bayer

Life Sciences

Bayer delivers science-driven health and agricultural solutions through globally recognized consumer brands, supported by substantial marketing investment to drive consumer awareness and loyalty.

Last updated Oct 25, 2026 by ATDb automated enrichment

Founded
1863
HQ
Leverkusen, North Rhine-Westphalia, Germany
Connections
1

AI-drafted from public sources1 source cited

At a glance

Employees
10001+
Revenue
>$40B
Stock
BAYRY

About

One of the world's largest life sciences companies and a top-tier global advertiser with a portfolio of iconic consumer health brands

Bayer AG is a German multinational corporation founded in 1863, headquartered in Leverkusen, Germany. The company operates across three core divisions: Pharmaceuticals (prescription medicines including oncology and cardiovascular drugs), Consumer Health (over-the-counter brands such as Aspirin, Aleve, Claritin, Coppertone, and Dr. Scholl's), and Crop Science (agrochemicals and seeds, significantly expanded through the 2018 acquisition of Monsanto for approximately $63 billion). Bayer is one of the world's largest companies by revenue, consistently ranking among the top global enterprises in the life sciences sector. As a major consumer health company, Bayer is a significant advertiser and marketer, investing heavily in brand-building campaigns across television, digital, social media, and out-of-home channels for its portfolio of household consumer brands. The company works with major advertising agencies and media buyers to reach consumers globally, making it a major client within the advertising and media ecosystem. Its Consumer Health division in particular drives substantial marketing spend to maintain brand awareness and market share for products like Aspirin and Claritin. Bayer's acquisition of Monsanto reshaped its scale and strategic focus but also brought significant legal and reputational challenges, particularly around glyphosate litigation. Despite these headwinds, Bayer remains a Fortune Global 500 company with revenues exceeding €40 billion annually and a workforce of approximately 100,000 employees worldwide. The company is publicly traded on the Frankfurt Stock Exchange and is a component of the DAX index.

Business model

Product Sales (Pharmaceuticals, Consumer Health, Crop Science)

Target market

Enterprise

What they offer

  • Aspirin

    Iconic over-the-counter pain relief and cardiovascular health brand marketed globally

  • Claritin

    Leading OTC allergy relief brand with significant consumer advertising spend

  • Aleve

    OTC pain reliever brand marketed heavily across TV and digital channels

  • Coppertone

    Sun care consumer brand with broad retail and marketing presence

  • Dr. Scholl's

    Foot care consumer brand distributed and marketed globally

  • Xarelto

    Prescription anticoagulant drug, one of Bayer's top pharmaceutical products

  • Roundup / Crop Science Portfolio

    Herbicides, seeds, and crop protection products acquired via Monsanto

Key features

Global portfolio of iconic consumer health brands with high advertising spendIntegrated pharmaceutical R&D and commercialization capabilitiesExtensive crop science and agricultural biotechnology portfolioMultinational distribution across 90+ countriesStrong direct-to-consumer marketing infrastructure

Use cases

Consumer health brand advertising across TV, digital, and social mediaDirect-to-consumer pharmaceutical marketing (where legally permitted)Retail co-marketing and promotional campaigns for OTC productsAgricultural product marketing to farmers and distributors

Customer segments

Consumers (OTC health products)Healthcare professionals and hospitalsFarmers and agricultural businessesRetail pharmacies and grocery chainsSpecialty distributors

Tech & specs

Technology stack

SAP ERPSalesforce CRMDigital marketing platformsProgrammatic advertising platforms

Security & compliance

GDPRFDA regulationsEMA complianceISO certifications

API

No

Corporate history
  1. 1863 · Founded
Connection details

Explore further

2 views